Literature DB >> 10534232

The role of nuclear cardiology in clinical decision making.

D S Berman1, G Germano, L J Shaw.   

Abstract

This review suggests that the field of nuclear cardiology is alive, well, and thriving, providing relevant information that aids in everyday clinical decision making for nuclear medicine and referring physicians alike. Despite the competition from other modalities, the clinically appropriate applications of nuclear cardiology techniques are likely to increase. The foundation of this optimism is based on the vast amount of data documenting cost-effective clinical applications for diagnosis, risk stratification, and assessing therapy in both chronic and acute coronary artery disease (CAD), the powerful objective quantitative analysis of perfusion and function provided by the technique, and the increasing general availability of the approach.

Entities:  

Mesh:

Year:  1999        PMID: 10534232     DOI: 10.1016/s0001-2998(99)80017-8

Source DB:  PubMed          Journal:  Semin Nucl Med        ISSN: 0001-2998            Impact factor:   4.446


  12 in total

1.  Evaluation of (99)  (m)TcN-MPO as a new myocardial perfusion imaging agent in normal dogs and in an acute myocardial infarction canine model: comparison with (99)  (m)Tc-sestamibi.

Authors:  Lihong Bu; Renfei Li; Zhongnan Jin; Xiaofei Wen; Shuang Liu; Baofeng Yang; Baozhong Shen; Xiaoyuan Chen
Journal:  Mol Imaging Biol       Date:  2011-02       Impact factor: 3.488

2.  A realistic 3-D gated cardiac phantom for quality control of gated myocardial perfusion SPET: the Amsterdam gated (AGATE) cardiac phantom.

Authors:  Jacco J N Visser; Ellinor Busemann Sokole; Hein J Verberne; Jan B A Habraken; Huybert J F van de Stadt; Joris E N Jaspers; Morgan Shehata; Paul M Heeman; Berthe L F van Eck-Smit
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-02       Impact factor: 9.236

3.  Revascularize only for ischemia, especially if left ventricular function is poor.

Authors:  Mark I Travin
Journal:  J Nucl Cardiol       Date:  2006-11       Impact factor: 5.952

4.  Observer variability in the evaluation of dual-isotope Tl-201/Tc-99m sestamibi rest/stress myocardial perfusion SPECT in men and women with known or suspected stable angina pectoris.

Authors:  Allan Johansen; Poul Flemming Høilund-Carlsen; Henrik Wulff Christensen; Peter Grupe; Annegrete Veje; Werner Vach; Torben Haghfelt
Journal:  J Nucl Cardiol       Date:  2004 Nov-Dec       Impact factor: 5.952

5.  Minimizing liver uptake of cationic Tc radiotracers with ether and crown ether functional groups.

Authors:  Young-Seung Kim; Fan Wang; Shuang Liu
Journal:  World J Hepatol       Date:  2010-01-27

6.  Use of myocardial perfusion imaging to predict the effectiveness of coronary revascularisation in patients with stable angina pectoris.

Authors:  Allan Johansen; Poul Flemming Høilund-Carlsen; Henrik Wulff Christensen; Werner Vach; Mette Møldrup; Torben Haghfelt
Journal:  Eur J Nucl Med Mol Imaging       Date:  2005-04-12       Impact factor: 9.236

7.  Tc-99m-N-MPO: novel cationic Tc-99m radiotracer for myocardial perfusion imaging.

Authors:  Young-Seung Kim; Jianjun Wang; Alexis Broisat; David K Glover; Shuang Liu
Journal:  J Nucl Cardiol       Date:  2008-04-21       Impact factor: 5.952

Review 8.  Adequate patient selection for coronary revascularization: an overview of current methods used in daily clinical practice.

Authors:  Steven A J Chamuleau; Berthe L F van Eck-Smit; Martijn Meuwissen; Jan J Piek
Journal:  Int J Cardiovasc Imaging       Date:  2002-02       Impact factor: 2.357

9.  Long-term prognostic value of CFVR and FFR versus perfusion scintigraphy in patients with multivessel disease.

Authors:  S A J Chamuleau; B L F van Eck-Smit; M Meuwissen; K T Koch; M G W Dijkgraaf; H J Verberne; J G P Tijssen; J J Piek
Journal:  Neth Heart J       Date:  2007       Impact factor: 2.380

10.  Reduction in downstream test utilization following introduction of coronary computed tomography in a cardiology practice.

Authors:  Ronald P Karlsberg; Matthew J Budoff; Louise E J Thomson; John D Friedman; Daniel S Berman
Journal:  Int J Cardiovasc Imaging       Date:  2009-12-05       Impact factor: 2.357

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.